Are influenza-associated morbidity and mortality estimates for those ≥65 in statistical databases accurate, and an appropriate test of influenza vaccine effectiveness?

Vaccine

Volumn 32, Issue 51, 2014, Pages 6884-6901

  Thomas, Roger E ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Databases; Influenza; Influenza vaccine effectiveness; Morbidity and mortality; RCTs; Statistical models

Indexed keywords

INFLUENZA VACCINE;

ACCURACY; AGING; CAUSE OF DEATH; COMORBIDITY; DEATH CERTIFICATE; DRUG EFFICACY; HOSPITALIZATION; HUMAN; INFLUENZA; INFLUENZA VACCINATION; MORBIDITY; MORTALITY; NURSING HOME; PANDEMIC INFLUENZA; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STATISTICAL MODEL; SYSTEMATIC REVIEW; AGED; EPIDEMIOLOGICAL MONITORING; FACTUAL DATABASE; IMMUNOLOGY; INFLUENZA, HUMAN; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; DATABASES, FACTUAL; EPIDEMIOLOGICAL MONITORING; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MODELS, STATISTICAL; TREATMENT OUTCOME;

EID: 84924028076     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.08.090     Document Type: Review

References (91)

1. Redlberger-Fritz M., Aberle J.H., Popow-Kraupp T., Kundi M. Attributable deaths due to influenza: a comparative study of seasonal and pandemic influenza. Eur J Epidemiol 2012, 27:567-575. 10.1007/s10654-012-9701-y.
2. Speers D.J., Moss D.M., Minney-Smith C., Levy A., Smith D.W. Influenza and respiratory syncytial virus are the major respiratory viruses detected from prospective testing of pediatric and adult coronial autopsies. Influenza Other Respir Viruses 2013, 7(6):1113-1121. 10.1111/irv.12139.
3. Nicoll A., Ciancio B.C., Chavarrias V.L., Mølbak K., Pebody R., Pedzinski B., et al. Influenza-related deaths-available methods for estimating numbers and detecting patterns for seasonal and pandemic influenza in Europe. Euro Surveill 2012, 17(18):1-13. http://www.eurosurveillance.org/ViewArticle.aspx?Articleid=20162.
4. Mølbak K., Widgren K., Jensen K.S., Ethelberg S., Andersen P.H., Christiansen A.H., et al. Burden of illness of the 2009 pandemic of influenza (H1N1) in Denmark. Vaccine 2011, 29(Suppl 2):B63-B69. 10.1016/j.vaccine.2011.03.064.
5. McGeer A., Campbell B., Emori T.G., Hierholzer W.J., Jackson M.M., Nicolle L.E., et al. Definitions of infection for surveillance in long-term care facilities. Am J Infect Control 1991, 19:1-7.
6. Chami K., Gavazzi G., Carrat F., de Wazières B., Lejeune B., Piette F., et al. Burden of infections among 44,869 elderly in nursing homes: a cross-sectional cluster nationwide survey. J Hosp Infect 2011, 79:254-259. 10.1016/j.jhin.2011.08.003.
7. Gaillat J., Chidiac C., Fagnani F., Pecking M., Salom M., Veyssier P.O., et al. Morbidity and mortality associated with influenza exposure in long-term care facilties for dependent elderly people. Eur J Clin Microbiol Infect Dis 2009, 28:1077-1086. 10.1007/s/10096-009-0751-3.
8. Registrar-General Tenth annual report of the Registrar-General 1847, H.M. Stationery Office, London.
9. Lemaitre M., Carrat F., Rey G., Miller M., Simonsen L., Viboud C. Mortality burden of the 2009 A/H1N1 influenza pandemic in France: comparison to seasonal influenza and the A/H3N2 pandemic. PLoS One 2012, 7(9):e45051.
10. López-Cuadrado, de Mateo S., Jiménez-Jorge S., Savulescu A.C., Larrauri A. Influenza-related mortality in Spain, 1999-2005. Gac Sanit 2012, 26(4):325-329.
11. Newall A.T., Viboud C., Wood J.G. Influenza-attributable mortality in Australians aged more than 50 years: a comparison of different modelling approaches. Epidemiol Infect 2010, 138:836-842. 10.1017/S095026880999118X.
12. Thompson W.W., Weintraub E., Dhankhar P., Cheng P.-Y., Brammer L., et al. Estimates of US influenza-associated deaths made using four different methods. Influenza Other Respir Viruses 2009, 3(1):37-49.
13. Gilca R., De Serres G., Skronowski D., Boivin G., Buckeridge D.L. The need for validation of statistical methods for estimating respiratory virus-attributable hospitalization. Am J Epidemiol 2009, 170(7):925-936. 10.1093/aje/kwp195.
14. Charu V., Simonsen L., Lustig R., Steiner C., Viboud C. Mortality burden of the 2009 influenza pandemic in the United States: improving the timeliness of influenza severity estimates using inpatient mortality records. Influenza Other Respir Viruses 2013, 7(5):863-871. 10.1111/irv.12096.
15. Hebert P.L., McBean A.M., Kane R.L. Explaining trends in hospitalizations for pneumonia and influenza in the elderly. Med Care Res Rev 2005, 62(5):560-582. 10.1177/1077558705279310.
16. Mytton O.T., Rutter P.D., Mak M., Stanton E.A.I., Sachedina N., et al. Mortality due to pandemic (H1N1) 2009 influenza in England: a comparison of the first and second waves. Epidemiol Infect 2012, 140:1533-1541. 10.1017/S0950268811001968.
17. Ortiz J.R., Neuzil K.M., Rue T.C., Zhou H., Shay D.K., Cheng P.-Y., et al. Population-based incidence estimates of influenza-associated respiratory failure hospitalizations, 2003 to 2009. Am J Respir Crit Care Med 2013, 188(6):710-715.
18. Schanzer D.L., Sevenhuysen C., Winchester B., Mersereau T. Estimating influenza deaths in Canada, 1992-2009. PLoS One 2013, 8(11):e80481.
19. Schanzer D.L., Tam T.W.S., Langley J.M., Winchester B.T. Influenza attributable deaths, Canada 1990-1999. Epidemiol Infect 2007, 135:1109-1116. 10.1017/S0950268807007923.
20. Schanzer D.L., Langley J.M., Tam T.W.S. Co-morbidities associated with influenza-attributed mortality, 1994-2000, Canada. Vaccine 2008, 26:4697-4703. 10.1016/j.vaccine.2008.06.087.
21. Simonsen L., Clarke M.J., Williamson G.D., Stroup D.F., Arden N.H., et al. The impact of influenza epidemics on mortality: introducing a severity index. Am J Pub Health 1997, 87(12):1944-1950. 10.1371/journal.pone.0080481.
22. van den Wijngaard C.C., van Asten L., Koopmans M.P.G., van Pelt W., Nagelkerke N.J.D., Wilders C.C.H. Comparing pandemic to seasonal mortality: moderate impact overall but high mortality in young children. PLoS One 2012, 7(2):e31197. 10.1371/journal/pone.0031197.
23. Wong C.-M., Chan K.-P., Hedley A.J., Peiris J.S.M. Influenza-associated mortality in Hong Kong. Clin Infect Dis 2004, 39:1611-1617.
24. Wu P., Goldstein E., Ho L.M., Yang L., Nishiura H., Wu J.T., et al. Excess mortality associated with influenza A and B virus in Hong Kong 1998-2009. J Infect Dis 2012, 206:1862-1871. 10.1093/infdis/jis628.
25. Nielsen J., Mazick A., Andrews N., Detsis M., Fenech T.M., Flores V.M., et al. Pooling European all-cause mortality: methodology and findings for the seasons 2008/2009 to 2010/2011. Epidemiol Infect 2013, 141:1996-2010. 10.1017/S0950268812002580.
26. Pin S.P., Golmard J.L., Cotto E., Rothan-Tondeur M., Chami K., Piette F. Excess winter mortality in France: influence of temperature, influenza like illness, and residential care status. J Am Med Dir Assoc 2012, 13(3):309. (e1-309.e7). 10.1016/j/jamda.2011.06.005.
27. von Klot S., Zanobetti A., Schwartz J. Influenza epidemics, seasonality and the effects of cold weather on cardiac mortality. Environ Health 2012, 11:74. http://www.ehjournal.net/content/11/1/74.
28. Azziz-Baumgartner E., Cabrera A.M., Cheng P.-Y., Garcia E., Kusznierz G., Calli R., et al. Incidence of influenza-associated mortality and hospitalizations in Argentina during 2002-2009. Influenza Other Respir Viruses 2012, 7(5):710-717. 10.1111/irv.12022.
29. Cohen C., Simonsen L., Kang J.-W., Miller M., McAnerney J., Blumberg L., et al. Elevated influenza-related excess mortality in South African elderly individuals, 1998-2005. Clin Infect Dis 2010, 51(12):1362-1369. 10.1086/657314.
30. de Oliveira J., de F.M., Boing A.F., Waldman E.A., Antunes J.L.F. Ecological study on mortality from influenza and pneumonia before and after influenza vaccination in the Northeast and South of Brazil. Cad Saúde Públ Rio de Janeiro 2013, 29(12):2535-2545. http://doi.org/10.1590/0102-31X00028413.
31. de Souza M., de F.M., Widdowson M.-A., Alencar A.P., Gawryszewski V.P., Aziz-Baumgartner E., et al. Trends in mortality from respiratory disease in Latin America since 1998 and the impact of the 2009 influenza pandemic. Bull World Health Organ 2013, 91:525-532. http://dx.doi.org/10.2471/BLT.12.116871.
32. Feng L., Shay D.K., Jiang Y., Zhou H., Chen X., Zheng Y., et al. Influenza-associated mortality in temperate and subtropical Chinese cities, 2003-2008. Bull World Health Organ 2012, 90:279-288B. 10.2471/BLT.11.096958.
33. Freitas A.R.R., Francisco P.M.S.B., Donalisio M.R. Mortality associated with influenza in tropics, State of São Paulo, Brazil, from 2002 to 2011: the pre-pandemic, pandemic, and post-pandemic periods. Influenza Res Treat 2013, 141:1731-1740. http://dx.doi.org/10.1155/2013/696274 (Article ID 696274, 9 pages).
34. Freitas F.T.M., Souza L.R.O., Azziz-Baumgartner E., Cheng P.Y., Zhou H., Widdowson M.A., et al. Influenza-associated excess mortality in southern Brazil, 1980-2008. Epidemiol Infect 2013, 141:1731-1740. 10.1017/S0950268812002221.
35. Gran J.M., Kacelnik O., Grjibovski A.M., Aavitsland P., Iversen B.G. Counting pandemic deaths: comparing reported numbers of deaths from influenza A(H1N1)pdm09 with estimated excess mortality. Influenza Other Respir Viruses 2013, 7(6):1370-1379. 10.1111/irv.12125.
36. Mazick A., Gergonne B., Nielsen J., Wuillaume F., Virtanen M.J., Foulliet A., et al. Excess mortality among the elderly in 12 European countries, February and March 2012. Euro Surveill 2012, 17(14). http://www.eurosurveillance.org/ViewArticler.aspx?ArticleId=20138.
37. Menec V.H., Black C., MacWilliam L., Aoki F.Y. The impact of influenza-associated respiratory illnesses on hospitalizations, physician visits, emergency room visits, and mortality. Can J Pub Health 2003, 94(1):59-63.
38. Muscatello D.J., Newall A.T., Dwyer D.E., MacIntyre C.R. Mortality attributable to seasonal and pandemic influenza, Australia, 2003 to 2009, using a novel time series smoothing approach. PLoS One 2013, 8(6):e64734. 10.1371/journal.pone.0064734.
39. Muscatello D.J., Cretikos M.A., MacIntyre C.R. All-cause mortality during first wave of pandemic (H1N1) 2009, New South Wales, Australia, 2009. Emerg Infect Dis 2010, 16(9):1396-1402. 10.3201/eid1609.091723.
40. Muscatello D.J., Morton P.M., Evans I., Gilmour R. Prospective surveillance of excess mortality due to influenza in New South Wales: feasibility and statistical approach. Commun Dis Intell Q Rep 2008, 32:435-442.
41. Nguyen A.M., Noymer A. Influenza mortality in the United States, 2009 pandemic: burden, timing and age distribution. PLoS One 2013, 8(5):e64198. 10.1371/journal.pone.0064198.
42. Nunes B., Viboud C., Machado A., Ringholz C., Rebelo-de Andrade H., Nogueira P., et al. Excess mortality associated with influenza epidemics in Portugal, 1980 to 2004. PLoS One 2011, 6(6):e20661. 10.1371/journal.pone.0020661.
43. Reichert T.A., Simonsen L., Sharma A., Pardo S.A., Fedson D.S., Miller M.A. Influenza and the winter increase in mortality in the United States, 1959-1999. Am J Epidemiol 2004, 160(5):492-502. 10.1093/aje/kwj227.
44. Simonsen L., Spreeuwenberg P., Lustig R., Taylor R.J., Fleming D.M., Kroneman M., et al. Global mortality estimates for the 2009 influenza pandemic from the GLaMOR Project: a modeling study. PLoS Med 2013, 10(11):e1001558. 10.1371/journal.pmed.1001558.
45. Campitelli M.C., Rosella L.C., Stukel T.A., Kwong J.C. Influenza vaccination and all-cause mortality in community-dwelling elderly in Ontario, Canada, a cohort study. Vaccine 2011, 29:240-246. 10.1016/j.vaccine.2010.10.049.
46. Wang C.-S., Wang S.-T., Lai C.-T., Lin L.-J., Chou P. Impact of influenza vaccination on major cause-specific mortality. Vaccine 2007, 25:1196-1203. 10.1016/j.vaccine.2006.10.015.
47. Antunes J.L.F., Waldman E.A., Borrell C., Paiva T.M. Effectiveness of influenza vaccination and its impact on health inequalities. Int J Epidemiol 2007, 36:1319-1326. 10.1093/ije/dym208.
48. Charu V., Viboud C., Simonsen L., Sturm-Ramirez K., Shinjoh M., Chowell G., et al. Influenza-related mortality in Japanese and American seniors: evidence for the indirect mortality benefits of vaccinating schoolchildren. PLoS One 2011, 6(11):e26282. 10.1371/journal.pone.0026282.
49. Mann A.G., Mangtani P., Russell C.A., Whittaker J.C. The impact of targeting all elderly persons in England and Wales for yearly influenza vaccination: excess mortality due to pneumonia or influenza and time trend study. BMJ Open 2013, 3:e002743. 10.1136/bmjopen-2013-002743.
50. Jansen A.G.S.C., Sanders E.A.M., Nichol K.L., van Loon A.M., Hoes A.W., Hak E. Decline in influenza-associated mortality among Dutch elderly following the introduction of a nationwide vaccination program. Vaccine 2008, 26:5567-5574. 10.1016/j.vaccine.2008.08.003.
51. Rizzo C., Viboud C., Montomoli E., Simonsen L., Miller M.A. Influenza-related mortality in the Italian elderly: no decline associated with increasing vaccination coverage. Vaccine 2006, 24:6468-6475. 10.1016/j.vaccine.2006.06.052.
52. Rizzo C., Bella A., Viboud C., Somonsen L., Miller M.A., Rota M.C., et al. Trends for influenza-related deaths during pandemic and epidemic seasons, Italy, 1969-2001. Emerg Infect Dis 2007, 13(5):684-699.
53. Simonsen L., Taylor R.J., Viboud C., Miller M.A., Jackson L.A. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis 2007, 7:658-666. 10.1016/50140-6736(07)61389-0.
54. Goldstein E., Viboud C., Charu V., Lipsitch M. Improving the estimation of influenza-related mortality over a seasonal baseline. Epidemiology 2012, 23(6):829-838. 10.1097/EDE.0b013e182632dda.
55. Wong J., Kelly H., Ip D., Wu J., Leung G., Cowling B. Case fatality risk of influenza A(H1N1pdm09): a systematic review. Epidemiology 2013, 24(6):830-841. 10.1097/EDE.0b013e3182a67448.
56. Hottes T.S., Skronowski D.M., Hiebert B., Janjua N.Z., Roos L.L., van Caeseele P., et al. Influenza vaccine effectiveness in the elderly based on administrative databases: change in immunization habit as a marker for bias. PLoS One 2011, 6(7):e22618. 10.1371/journaL.pone.0022618.
57. Voordouw B.C.G., Sturkenboom M.C.J.M., Dieleman J.P., Stijnen T., van der Lei J., Stricker B.H.C. Annual influenza vaccination in community-dwelling elderly individuals and the risk of lower respiratory tract infections or pneumonia. Arch Intern Med. 2006, 166:1980-1985.
58. Voordouw B.C.G., van der Linden P.D., Simonian S., van der Lei J., Sturkenboom M.C.J.M., Stricker B.H.C. Influenza vaccination in community-dwelling elderly: impact on mortality and influenza-associated morbidity. Arch Intern Med 2003, 163:1089-1094.
59. Voordouw B.C.G., Sturkenboom M.C.J.M., Dieleman J.P., Stijnen T., Smith D.J., van der Lei J., et al. Annual revaccination against influenza in community-dwelling elderly persons. JAMA 2004, 292(17):2089-2095.
60. Jackson M.L., Yu O., Nelson J.C., Naleway A., Belongia E.A., Baxter R., et al. Further evidence for bias in observational studies of influenza vaccine effectiveness: the 2009 influenza A(H1N1) pandemic. Am J Epidemiol 2013, 178(8):1327-1336. 10.1093/aje/kwt124.
61. Nelson J.C., Marsh T., Lumley T., Larson E.B., Jackson L.A., Jackson M.L., et al. Validation sampling can reduce bias in health care database studies: an illustration using influenza vaccination effectiveness. J Clin Epidemiol 2013, 66:S110-S121. http://dx.doi.org/10/1016/j.jclinepi.2013.01.015.
62. Fireman B., Lee J., Lewis N., Bembom O., van der Laan M., Baxter R. Influenza vaccination and mortality: differentiating vaccine effects from bias. Am J Epidemiol 2009, 170(5):650-656. 10.1093/aje/kwp173.
63. Baxter R., Lee J., Fireman B. Evidence of bias in studies of influenza vaccine effectiveness in elderly patients. J Infect Dis 2010, 201:186-189. 10.1086/649568.
64. Jackson M.L., Nelson J.C., Weiss N.S., Neuzil K.M., Barlow W., Jackson L.A. Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study. Lancet 2008, 372:398-405.
65. Jackson L.A., Nelson J.C., Benson P., Neuzil K.M., Reid R.J., Psaty B.M., et al. Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. Int J Epidemiol 2006, 35:345-352. 10.1093/ije/dyi275.
66. Jackson L.A., Jackson M.L., Nelson J.C., Neuzil K.M., Weiss N.S. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol 2006, 35:337-344. 10.1093/ije/dyi274.
67. Landi F., Onder G., Cesari M., Russo A., Barillaro C., Bernabei R. In a prospective observational study, influenza vaccination prevented hospitalization among older home care patients. J Clin Epidemiol 2006, 59:1072-1077. 10.1016/j.clinepi.2006.02.017.
68. Liu I.-F., Huang C.-C., Chan W.-L., Huang P.-H., Chung C.-M., Lin S.-J., et al. Effects of annual influenza vaccination on mortality and hospitalization in elderly patients with ischemic heart disease: a nationwide population-based study. Prev Med 2012, 54:431-433. 10.1016/j.ypmed.2012.03.020.
69. Liu I.-F., Leu H.-B. A rebuttal to "A new discussion for Effects of annual influenza vaccination on mortality and hospitalization in elderly patients with ischemic heart disease: a nationwide population-based study. Prev Med 2013, 57:69.
70. Mangtani P., Cumberland P., Hodgson C.R., Roberts J.A., Cutts F.T., Hall A.J. A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom General Practice Research Database. J Infect Dis 2004, 190:1-10.
71. Ridenhour B.J., Campitelli M.A., Kwong J.C., Rosella L.C., Armstrong B.G., Mangtani P., et al. Effectiveness of inactivated influenza vaccines in preventing influenza-associated deaths and hospitalizations among Ontario residents aged ≥65 years: estimates with generalized linear models accounting for healthy vaccinee effects. PLoS One 2013, 8(10):e76318. 10.1371/journal.pone.0076318.
72. Schembri S., Morant S., Winter J.H., MacDonald T.M. Influenza but not pneumococcal vaccination protects against all-cause mortality in patients with COPD. Thorax 2009, 64:567-572. 10.1136/thx.2008.106286.
73. Vila-Córcoles A., Rodriguez T., de Diego C., Ochoa O., Valdivieso A., Salsench E., et al. Effect of influenza vaccine status on winter mortality in Spanish community-dwelling elderly people during 2002-2005 influenza periods. Vaccine 2007, 25:6699-6707. 10.1016/j.vaccine.2007.07.015.
74. de Diego C., Vila-Córcoles A., Ochoa O., Rodriguez-Blanco T., Salsench E., Hospital I., et al. Effects of annual influenza vaccination on winter mortality in elderly people with heart disease. Eur Heart J 2009, 30:209-216. 10.10936/eurheart.ehn498.
75. Wong K., Campitelli M.A., Stukel T.A., Kwong J.C. Estimating influenza vaccine effectiveness in community-dwelling elderly patients using the instrumental variable analysis method. Arch Intern Med 2012, 172(6):484-491. 10.1001/archinternmed.2011.2038.
76. Simonsen L., Reichert T.A., Viboud C., Blackwelder W.C., Taylor R.J., Miller M.A. Impact of influenza vaccination on seasonal mortality in the US elderly population. Arch Intern Med 2005, 165:265-272.
77. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Cox N., Anderson L.J., et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003, 289(2):179-185.
78. Thomas R.E. Is influenza-like illness a useful concept and is it appropriate to assess influenza vaccine efficiency?. Vaccine 2014, 32:2143-2149. http://dx.doi.org/10.1016/j.vaccine.2014.02.059 80.
79. Bloom-Feshbach K., Alonso W.J., Charu V., Tamerius J., Simonsen L., Miller M.A., Viboud C. Latitudinal variations in seasonal activity of influenza and respiratory syncytial virus (RSV): a global comparative review. PLoS One 2013, 8(2):e54445. 10.1371/journal.pone.0054445.
80. Groenwold R.H.H., Klungel O.H., Altman D.G., van der Graaf Y., Hoes A.W., Moons K.G.M., et al. Adjustment for continuous confounders: an example of how to prevent residual confounding. Can Med Assoc J 2013, 185(5):401-406. 10.1503/cmaj.120592.
81. Simonsen L., Viboud C., Taylor R.J., Miller M.A., Jackson L. Influenza vaccination and mortality benefits: new insights, new opportunities. Vaccine 2009, 27:6300-6304. 10.1016/j.vaccine.2009.07.008.
82. Jackson M.L. Confounding by season in ecologic studies of seasonal exposures and outcomes: examples from estimates of mortality due to influenza. Ann Epidemiol 2009, 19:681-691. 10.1016/j.annepidem.2009.06.009.
83. Mori M., Oura A., Ohnishi H., Washio M. Confounding in evaluating the effectiveness of influenza vaccine. Vaccine 2008, 26:6459-6461. 10.1016/j.vaccine.2008.06.040.
84. Nelson J.C., Jackson M.L., Weiss N.S., Jackson L.A. New strategies are needed to improve the accuracy of influenza vaccine effectiveness estimates among seniors. J Clin Epidemiol 2009, 62:687-694. 10.1016/jclinepi.2008.06.014.
85. Chowell G., Viboud C. Lessons learned from case fatality risk estimates of 2009 pandemic influenza. Epidemiology 2013, 24(6):842-844. 10.1097/01.ede.0000434434.52506.bc.
86. Andreasen V., Simonsen L. The perils of using annual all-cause mortality data to estimate pandemic influenza burden. Vaccine 2011, 295:B49-B55. 10.1016/j.vaccine.2011.03.061.
87. Govaert T.M., Thijs CTMCN, Masurel N., Sprenger M.J.W., Dinant G.J., Knottnerus J.A. The efficacy of influenza vaccination in elderly individuals. JAMA 1994, 272:1661-1665.
88. Goodwin K., Viboud C., Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2005, 24:1159-1169.
89. Keitel W.A., Atmar R.L., Cate T.R., Petersen N.J., Greenberg S.B., Ruben F., et al. Safety of high doses of influenza vaccine and effect on antibody responses in elderly persons. Arch Intern Med 2006, 166:1121-1127.
90. Minutello M., Senatore F., Cecchinelli G., Bianchi M., Andreani T., Podda A., et al. Safety and immunogenicity of an inactivated subunit influenza virus vaccine combined with MF59 adjuvant emulsion in elderly subjects, immunized for three consecutive influenza seasons. Vaccine 1999, 17:99-104.
91. Treanor J.J., Mattison H.R., Dumyati G., Yinnon A., Erb S., O'Brien D., et al. Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly. Ann Intern Med 1992, 117:625-633.